Chembio Diagnostics Submits EUA Application for New DPP SARS-CoV-2 Antigen Test
November 16, 2021 16:05 ET
|
Chembio Diagnostics, Inc.
HAUPPAUGE, N.Y., Nov. 16, 2021 (GLOBE NEWSWIRE) -- Chembio Diagnostics, Inc. (Nasdaq: CEMI), a leading point-of-care diagnostics company focused on infectious diseases, today announced the...
Chembio Diagnostics Announces Extension of Delivery Schedule for Bio Manguinhos Purchase Order of DPP SARS-COV-2 Antigen Tests
November 15, 2021 08:00 ET
|
Chembio Diagnostics, Inc.
HAUPPAUGE, N.Y., Nov. 15, 2021 (GLOBE NEWSWIRE) -- Chembio Diagnostics, Inc. (“Chembio”) (Nasdaq: CEMI), a leading point-of-care diagnostics company focused on infectious diseases, today announced...
Chembio Diagnostics Reports Third Quarter 2021 Financial Results
November 04, 2021 16:05 ET
|
Chembio Diagnostics, Inc.
HAUPPAUGE, N.Y., Nov. 04, 2021 (GLOBE NEWSWIRE) -- Chembio Diagnostics, Inc. (“Chembio” or the “Company”) (Nasdaq: CEMI), a leading point-of-care diagnostics company focused on infectious diseases,...
Chembio Diagnostics to Report Third Quarter 2021 Financial Results on November 4, 2021
October 21, 2021 16:51 ET
|
Chembio Diagnostics, Inc.
HAUPPAUGE, N.Y., Oct. 21, 2021 (GLOBE NEWSWIRE) -- Chembio Diagnostics, Inc. (Nasdaq: CEMI), a leading point-of-care diagnostics company focused on infectious diseases, announced today that it will...
Chembio Announces EUA Submission for DPP Respiratory Antigen Panel
September 22, 2021 08:00 ET
|
Chembio Diagnostics, Inc.
HAUPPAUGE, N.Y., Sept. 22, 2021 (GLOBE NEWSWIRE) -- Chembio Diagnostics, Inc. (Nasdaq: CEMI), a leading point-of-care diagnostics company focused on infectious diseases, today announced the...
Chembio Launches Commercial Distribution of Third-Party COVID-19 Antigen Assay
August 27, 2021 08:00 ET
|
Chembio Diagnostics, Inc.
HAUPPAUGE, N.Y., Aug. 27, 2021 (GLOBE NEWSWIRE) -- Chembio Diagnostics, Inc. (Nasdaq: CEMI), a leading point-of-care diagnostics company focused on infectious diseases, today announced its launch of...
Chembio Diagnostics Reports Second Quarter 2021 Financial Results
August 05, 2021 16:05 ET
|
Chembio Diagnostics, Inc.
HAUPPAUGE, N.Y., Aug. 05, 2021 (GLOBE NEWSWIRE) -- Chembio Diagnostics, Inc. (“Chembio” or the “Company”) (Nasdaq: CEMI), a leading point-of-care diagnostics company focused on infectious diseases,...
Chembio Diagnostics to Report Second Quarter 2021 Financial Results on August 5, 2021
July 22, 2021 17:03 ET
|
Chembio Diagnostics, Inc.
HAUPPAUGE, N.Y., July 22, 2021 (GLOBE NEWSWIRE) -- Chembio Diagnostics, Inc. (Nasdaq: CEMI), a leading point-of-care diagnostics company focused on infectious diseases, announced today that it will...
Chembio Diagnostics Receives $4 Million HIV Test Purchase Order Supported by The Global Fund
July 22, 2021 12:49 ET
|
Chembio Diagnostics, Inc.
HAUPPAUGE, N.Y., July 22, 2021 (GLOBE NEWSWIRE) -- Chembio Diagnostics, Inc. (Nasdaq: CEMI), a leading point-of-care diagnostic company focused on infectious diseases, announced its receipt today of...
Chembio Diagnostics Receives $28.3 Million Purchase Order from Bio-Manguinhos for DPP SARS-CoV-2 Antigen Tests in Brazil
July 20, 2021 22:56 ET
|
Chembio Diagnostics, Inc.
HAUPPAUGE, N.Y., July 20, 2021 (GLOBE NEWSWIRE) -- Chembio Diagnostics, Inc. (Nasdaq: CEMI), a leading point-of-care diagnostic company focused on infectious diseases, announced its receipt today of...